T
Tenax Therapeutics Inc (TENX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$1.48
-0.14 (-8.64%)
Market Cap: $73.77M
Last updated: Nov 17, 2026 at 11:05 AM ET
Tenax Therapeutics Inc (TENX) Valuation Multiples
Tenax Therapeutics (TENX) trades at 0.7x book value. Its P/B of 0.7x is below its 5-year median of 1.0x. Its forward P/E is 0.3x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 0.3x |
| Price to book | 0.7x |
| EV/FCF | 0.7x |
| PEG | N/A |
| FCF yield | -62.4% |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.7x | 1.0x | N/A |
Valuation History
Over the 5 of the 10 year ends shown that have a P/B, its P/B ranged from 0.7x in 2023 to 6.2x in 2021.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $12.19 | N/A | 4.9x |
| 2024 | $6.19 | N/A | 1.0x |
| 2023 | $21.97 | 942.6x | 0.7x |
| 2022 | $178.24 | N/A | 2.0x |
| 2021 | $1,664.00 | N/A | 6.2x |
| 2020 | $2,976.00 | N/A | N/A |
| 2019 | $2,256.00 | N/A | N/A |
| 2018 | $1,936.00 | N/A | N/A |
| 2017 | $15,680.00 | N/A | N/A |
| 2016 | $62,400.00 | N/A | N/A |
Frequently Asked Questions About TENX
What is TENX's forward P/E ratio?
Tenax Therapeutics has a forward P/E ratio of 0.3x.
TENX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors